154 related articles for article (PubMed ID: 38506024)
1. [Neurofibromatosis type 2 in the otorhinolaryngological practice].
Subbotina MV; Berseneva AV
Vestn Otorinolaringol; 2024; 89(1):37-41. PubMed ID: 38506024
[TBL] [Abstract][Full Text] [Related]
2. Management of Neurofibromatosis Type 2-Associated Vestibular Schwannomas.
Jiramongkolchai P; Schwartz MS; Friedman RA
Otolaryngol Clin North Am; 2023 Jun; 56(3):533-541. PubMed ID: 36964092
[TBL] [Abstract][Full Text] [Related]
3. Dermatologic manifestations in paediatric neurofibromatosis type 2: a cross sectional descriptive multicentric study.
Legoupil S; Bessis D; Picard F; Mallet S; Mazereeuw J; Phan A; Dupin-Deguine D; Kalamarides M; ; Chiaverini C
Orphanet J Rare Dis; 2022 Jun; 17(1):242. PubMed ID: 35729665
[TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
Welling DB
Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
[TBL] [Abstract][Full Text] [Related]
5. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
[TBL] [Abstract][Full Text] [Related]
6. [Neurofibromatosis].
Wolkenstein P; Decq P
Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
Sun S; Liu A
J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
[TBL] [Abstract][Full Text] [Related]
8. [Bilateral intracochlear schwannomas in a patient with no genetic or clinical features of neurofibromatosis type 2. German version].
Withers S; Plontke SK; Boeddinghaus R; Kuthubutheen J; Atlas M
HNO; 2020 Jul; 68(7):534-538. PubMed ID: 31758201
[TBL] [Abstract][Full Text] [Related]
9. Astrocytic hamartoma of the optic disc and multiple café-au-lait macules in a child with neurofibromatosis type 2.
Sachdeva R; Rothner DA; Traboulsi EI; Hayden BC; Rychwalski PJ
Ophthalmic Genet; 2010 Dec; 31(4):209-14. PubMed ID: 21067482
[TBL] [Abstract][Full Text] [Related]
10. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
[TBL] [Abstract][Full Text] [Related]
11. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
Fisher LM; Doherty JK; Lev MH; Slattery WH
Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
[TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis Type 2.
Ardern-Holmes S; Fisher G; North K
J Child Neurol; 2017 Jan; 32(1):9-22. PubMed ID: 27655473
[TBL] [Abstract][Full Text] [Related]
13. Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies.
Ruggieri M; Praticò AD; Serra A; Maiolino L; Cocuzza S; Di Mauro P; Licciardello L; Milone P; Privitera G; Belfiore G; Di Pietro M; Di Raimondo F; Romano A; Chiarenza A; Muglia M; Polizzi A; Evans DG
Acta Otorhinolaryngol Ital; 2016 Oct; 36(5):345-367. PubMed ID: 27958595
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.
Ruggieri M; Praticò AD; Evans DG
Semin Pediatr Neurol; 2015 Dec; 22(4):240-58. PubMed ID: 26706012
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis 2 in the pediatric age group.
Mautner VF; Tatagiba M; Guthoff R; Samii M; Pulst SM
Neurosurgery; 1993 Jul; 33(1):92-6. PubMed ID: 8355853
[TBL] [Abstract][Full Text] [Related]
17. Bilateral intracochlear schwannomas in a patient with no genetic or clinical features of neurofibromatosis type 2.
Withers S; Plontke SK; Boeddinghaus R; Kuthubutheen J; Atlas M
HNO; 2020 Jan; 68(Suppl 1):60-64. PubMed ID: 31598774
[TBL] [Abstract][Full Text] [Related]
18. A Bilateral Vestibular Schwannoma is Not Always Related to Neurofibromatosis Type 2.
Abeshi A; Ferri GG
J Int Adv Otol; 2023 Jun; 19(3):263-265. PubMed ID: 37272647
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2.
Mautner VF; Nguyen R; Kutta H; Fuensterer C; Bokemeyer C; Hagel C; Friedrich RE; Panse J
Neuro Oncol; 2010 Jan; 12(1):14-8. PubMed ID: 20150363
[TBL] [Abstract][Full Text] [Related]
20. Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas.
Kruyt IJ; Verheul JB; Hanssens PEJ; Kunst HPM
J Neurosurg; 2018 Jan; 128(1):49-59. PubMed ID: 28128697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]